Literature DB >> 16451769

Neuroendocrine tumors.

Orlo H Clark1, Jaffer Ajani, Al B Benson, David Byrd, Gerard M Doherty, Paul F Engstrom, David S Ettinger, John F Gibbs, Martin J Heslin, Fouad Kandeel, Anne Kessinger, Matthew H Kulke, Larry Kvols, Albert A Nemcek, John A Olson, Thomas W Ratliff, Leonard Saltz, David E Schteingart, Manisha H Shah, Stephen Shibata.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16451769     DOI： 10.6004/jnccn.2006.0013

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  4 in total

Review 1.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 2.  Transarterial approaches to primary and secondary hepatic malignancies.

Authors:  Ali Habib; Kush Desai; Ryan Hickey; Bartley Thornburg; Robert Lewandowski; Riad Salem
Journal:  Nat Rev Clin Oncol       Date:  2015-05-19       Impact factor: 66.675

3.  Duodenal enteroglucagonoma revealed by differential comparison of serum and tissue glucagon reactivity with Siemens' Double Glucagon Antibody and DakoCytomation's Polyclonal Rabbit Anti-Human Glucagon: a case report.

Authors:  Wesley B Vanderlan; Ziying Zhang; Marwan S Abouljoud
Journal:  J Med Case Rep       Date:  2010-06-15

4.  Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model.

Authors:  Duc Do Minh; Julius Chapiro; Boris Gorodetski; Qiang Huang; Cuihong Liu; Susanne Smolka; Lynn Jeanette Savic; David Wainstejn; MingDe Lin; Todd Schlachter; Bernhard Gebauer; Jean-François Geschwind
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.